Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-11723905-B2 United States of America 15 Aug 2023
Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation Grant US-11497743-B2 United States of America 15 Nov 2022
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant US-11498913-B2 United States of America 15 Nov 2022
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1) Grant US-11311527-B2 United States of America 26 Apr 2022
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation Grant US-11013734-B2 United States of America 25 May 2021
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1) Grant US-11013733-B2 United States of America 25 May 2021
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10959994-B2 United States of America 30 Mar 2021
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Grant US-10889567-B2 United States of America 12 Jan 2021
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA BY… Application WO-2020094609-A1 World Intellectual Property Organisation (WIPO) 14 May 2020
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Application US-10550098-B2 United States of America 04 Feb 2020
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors Application US-10550099-B2 United States of America 04 Feb 2020
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6… Grant US-10532047-B2 United States of America 14 Jan 2020
COMBINATION OF MIDH1 INHIBITORS AND DNA HYPOMETHYLATING AGENTS (HMA) Application WO-2019025256-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2019